Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: A randomised trial

The Lancet

Volumn 387, Issue 10019, 2016, Pages 671-678

  Ruperto, Nicolino ^a   Pistorio, Angela ^a   Oliveira, Sheila ^b   Zulian, Francesco ^c   Cuttica, Ruben ^d   Ravelli, Angelo ^a,e   Fischbach, Michel ^f   Magnusson, Bo ^g   Sterba, Gary ^h   Avcin, Tadej ⁱ   Brochard, Karine ^j   Corona, Fabrizia ^k   Dressler, Frank ^l   Gerloni, Valeria ^m   Apaz, Maria T ⁿ   Bracaglia, Claudia ^o   Cespedes Cruz, Adriana ^p   Cimaz, Rolando ^q   Couillault, Gerard ^r   Joos, Rik ^s   Quartier, Pierre ^t   Russo, Ricardo ^u   Tardieu, Marc ^v   Wulffraat, Nico ^w   Bica, Blanca ^b   Dolezalova, Pavla ^x   Ferriani, Virginia ^y   Flato, Berit ^z   Bernard Medina, Ana G ^aa   Herlin, Troels ^ab   Trachana, Maria ^ac   Meini, Antonella ^ad   Allain Launay, Emma ^ae   Pilkington, Clarissa ^af   Vargova, Veronika ^ag   Wouters, Carine ^ah   Angioloni, Simona ^a   Martini, Alberto ^a,e   more..

^a G GASLINI INSTITUTE   (Italy)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Unità di Reumatologia Pediatrica   (Italy)

^d HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE   (Argentina)

^e UNIVERSITY OF GENOA   (Italy)

^f HÔPITAL DE HAUTEPIERRE   (France)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h Hospital de Clinicas Caracas   (Venezuela)

ⁱ UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^j HÔPITAL DES ENFANTS   (France)

^k FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^l HANNOVER MEDICAL SCHOOL   (Germany)

^m ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

ⁿ UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

^o BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^p INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^q UNIVERSITY OF FLORENCE   (Italy)

^r Medical University of Dijon   (France)

^s GHENT UNIVERSITY HOSPITAL   (Belgium)

^t UNIVERSITÉ PARIS DESCARTES   (France)

^u HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^v ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^w UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^x CHARLES UNIVERSITY   (Czech Republic)

^y UNIVERSITY OF SÃO PAULO   (Brazil)

^z OSLO UNIVERSITY HOSPITAL   (Norway)

^aa HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^ab AARHUS UNIVERSITY HOSPITAL   (Denmark)

^ac ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^ad UNIVERSITY OF BRESCIA   (Italy)

^ae NANTES UNIVERSITY HOSPITAL   (France)

^af UNIVERSITY COLLEGE LONDON   (United Kingdom)

^ag First Pediatric Department   (Slovakia)

^ah UNIVERSITY HOSPITALS LEUVEN   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CREATININE; CYCLOSPORIN A; METHOTREXATE; PREDNISONE; ANTIINFLAMMATORY AGENT; CYCLOSPORIN; DERMATOLOGICAL AGENT;

ABDOMINAL PAIN; ABNORMAL LABORATORY RESULT; ALOPECIA; APPENDICITIS; ARTICLE; CALCINOSIS; CHILD; COMBINATION CHEMOTHERAPY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CONVULSION; CREATININE BLOOD LEVEL; CUSHING SYNDROME; CUSHINGOID SYNDROME; DEEP VEIN THROMBOSIS; DERMOHYPODERMITIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EROSIVE GASTRITIS; EYE DISEASE; FEMALE; FOLLOW UP; FRIEDMAN TEST; HAIR LOSS; HEADACHE; HEART PALPITATION; HEPATITIS; HIRSUTISM; HUMAN; HYPERSENSITIVITY; HYPERTENSION; HYPERTRICHOSIS; INFECTION; INFESTATION; INJECTION SITE EDEMA; INTENTION TO TREAT ANALYSIS; JUVENILE DERMATOMYOSITIS; KAPLAN MEIER METHOD; KRUSKAL WALLIS TEST; LOG RANK TEST; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METABOLIC DISORDER; MONOTHERAPY; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NAUSEA; NAUSEA AND VOMITING; NUTRITIONAL DISORDER; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SEPSIS; SIDE EFFECT; SKIN ABSCESS; SKIN DISEASE; SURVIVAL; TACHYCARDIA; TREATMENT OUTCOME; UPPER ABDOMINAL PAIN; VASCULAR DISEASE; VOMITING; WEIGHT GAIN; ADOLESCENT; ANALYSIS OF VARIANCE; CLINICAL TRIAL; DERMATOMYOSITIS; DRUG ADMINISTRATION; DRUG COMBINATION; PRESCHOOL CHILD;

ADOLESCENT; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DERMATOLOGIC AGENTS; DERMATOMYOSITIS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; METHOTREXATE; PREDNISONE; TREATMENT OUTCOME;

EID: 84957900878     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)01021-1     Document Type: Article

References (28)

1. A Ravelli, L Trail, C Ferrari et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients Arthritis Care Res (Hoboken) 62 2010 63 72
2. BM Feldman, LG Rider, AM Reed, LM Pachman Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood Lancet 371 2008 2201 2212
3. EP Mendez, R Lipton, R Ramsey-Goldman et al. US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry Arthritis Rheum Arthritis Care Res 49 2003 300 305
4. PA Gordon, JB Winer, JE Hoogendijk, EH Choy Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis Cochrane Database Syst Rev 8 2012 CD003643.
5. R Hasija, A Pistorio, A Ravelli et al. Approaches for the treatment of new onset and flared juvenile dermatomyositis: an international multicenter PRINTO study Arthritis Rheum 63 2011 3142 3152
6. D Guseinova, A Consolaro, L Trail et al. Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis Clin Exp Rheumatol 29 2011 117 124
7. SM Al Mayouf, RM Laxer, R Schneider, ED Silverman, BM Feldman Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety J Rheumatol 27 2000 2498 2503
8. S Al-Mayouf, A Al-Mazyed, S Bahabri Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate Clin Rheumatol 19 2000 138 141
9. J Heckmatt, C Saunders, AM Peters et al. Cyclosporin in juvenile dermatomyositis Lancet 333 1989 1063 1066
10. N Ruperto, A Martini for the Paediatric Rheumatology International Trials Organisation (PRINTO) Networking in pediatrics: the example of the Pediatric Rheumatology International Trials Organisation (PRINTO) Arch Dis Child 96 2011 596 601
11. A Bohan, JB Peter Polymyositis and dermatomyositis (first of two parts) N Engl J Med 292 1975 344 347
12. A Bohan, JB Peter Polymyositis and dermatomyositis (second of two parts) N Engl J Med 292 1975 403 407
13. N Ruperto, A Ravelli, KJ Murray et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis Rheumatology (Oxford) 42 2003 1452 1459
14. N Ruperto, A Ravelli, A Pistorio et al. The provisional Pediatric Rheumatology International Trial Organization/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study Arthritis Rheum 59 2008 4 13
15. N Ruperto, A Pistorio, A Ravelli et al. The pediatric rheumatology international trials organization provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis Arthritis Care Res 62 2010 1533 1541
16. DJ Lovell, CB Lindsley, RM Rennebohm et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: II - the Childhood Myositis Assessment Scale (CMAS), a quantitative tool for the evaluation of muscle function Arthritis Rheum 42 1999 2213 2219
17. LG Rider, BM Feldman, MD Perez et al. Development of validated disease activity and damage indices for the juvenile idiophatic inflammatory myopathies: I - physician, parent, and patients global assessments Arthritis Rheum 40 1997 1976 1983
18. RK Bode, MS Klein-Gitelman, ML Miller, TS Lechman, LM Pachman Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence Arthritis Rheum 49 2003 7 15
19. G Singh, BH Athreya, JF Fries, DP Goldsmith Measurement of health status in children with juvenile rheumatoid arthritis Arthritis Rheum 37 1994 1761 1769
20. N Ruperto, A Ravelli, A Pistorio et al. Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries: review of the general methodology Clin Exp Rheumatol 19 2001 S1 S9
21. JM Landgraf, L Abetz, JE Ware The CHQ user's manual 1st edn. 1996 The Health Institute, New England Medical Center Boston
22. CV Oddis, LG Rider, AM Reed et al. International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies Arthritis Rheum 52 2005 2607 2615
23. N Ruperto, A Ravelli, R Cuttica et al. The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set Arthritis Rheum 52 2005 2854 2864
24. LG Rider, K Prasad, BM Feldman et al. Relationships among laboratory tests and global disease activity assessments in juvenile dermatomyositis Arthritis Rheum 39 suppl 1996 S191
25. LG Rider Assessment of disease activity and its sequelae in children and adults with myositis Curr Opin Rheumatol 8 1996 495 506
26. AV Ramanan, BM Feldman The role of muscle enzymes in JDM Pediatr Rheumatol Online J 3 2005 1 4
27. A Sansome, V Dubowitz Intravenous immunoglobulin in juvenile dermatomyositis: four year review of nine cases Arch Dis Child 72 1995 25 28
28. CV Oddis, AM Reed, R Aggarwal et al. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial Arthritis Rheum 65 2013 314 324